Not Everything Is Psoriasis
Rheumatology (Bulgaria) · 30.06.2026 · 34 (2) · 198-211
DOI: 10.35465/vyp0zd27 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology (Bulgaria), online erschienen am 30.06.2026. Verfasst von Krasimir Kraev und 9 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Psoriatic arthritis is a chronic inflammatory musculoskeletal disease associated with psoriasis and characterized by heterogeneous clinical manifestations. Idiopathic inflammatory myopathies and antisynthetase syndrome are distinct autoimmune entities that may rarely coexist with psoriasis or psoriatic arthritis, creating diagnostic and therapeutic challenges. Case presentation: We present the case of a 42-year-old woman initially diagnosed with psoriatic arthritis after presenting with recurrent knee arthritis accompanied by mild effusion and biopsy-confirmed psoriasis vulgaris localized to the left elbow. The patient fulfilled the CASPAR classification criteria and was initially treated with conventional disease-modifying antirheumatic drugs without satisfactory response. Subsequent treatment with secukinumab also failed to achieve disease control. Despite medical recommendations, the patient continued intermittent intramuscular corticosteroid administration prescribed elsewhere for symptomatic relief. Several months later, she was reevaluated because of persistent musculoskeletal complaints and progressive muscle weakness. Physical examination revealed severe proximal muscle weakness, including inability to rise from a prone position. Laboratory investigations demonstrated markedly elevated creatine phosphokinase levels exceeding 3000 U/L. Myositis-specific antibody testing revealed strongly positive anti-Jo-1 antibodies. The diagnosis was revised to inflammatory myopathy compatible with antisynthetase syndrome overlap, and treatment with systemic corticosteroids and azathioprine was initiated.
Conclusions
This case highlights the importance of continuous diagnostic reassessment in patients with presumed refractory psoriatic arthritis. Fulfillment of classification criteria should not preclude consideration of additional autoimmune diseases when atypical manifestations emerge. The temporal association with secukinumab also raises the possibility of biologic-related unmasking or triggering of inflammatory myopathy, although causality cannot be established.
Zitieren
APA
Kraev, K., Hristeva, V., Sokolov, I., Miteva-Ilieva, G., Popova-Belova, S., Yanakiev, I., Dzhambazova, S., Uchikova, M., Basheva-Kraeva, Y., & Geneva-Popova, M. (2026). Not Everything Is Psoriasis. Rheumatology (Bulgaria), 34(2), 198-211. https://doi.org/10.35465/vyp0zd27
Vancouver
Kraev K, Hristeva V, Sokolov I, Miteva-Ilieva G, Popova-Belova S, Yanakiev I, et al. Not Everything Is Psoriasis. Rheumatology (Bulgaria). 2026;34(2):198-211. doi:10.35465/vyp0zd27
BibTeX
@article{Kraev2026,
author = {Kraev, Krasimir and Hristeva, Vesela and Sokolov, Ivaylo and Miteva-Ilieva, Gergana and Popova-Belova, Stanislava and Yanakiev, Ivan and Dzhambazova, Sanie and Uchikova, Maria and Basheva-Kraeva, Yordanka and Geneva-Popova, Mariela},
title = {Not Everything Is Psoriasis},
journal = {Rheumatology (Bulgaria)},
year = {2026},
volume = {34},
number = {2},
pages = {198--211},
doi = {10.35465/vyp0zd27}
}
EUVIMED